Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Inovio Pharmaceuticals, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($167.5M and $166.6M). Across the 9 metrics below, Inovio Pharmaceuticals, Inc. leads on 5 and Zentalis Pharmaceuticals, Inc. on 4.

Valuation

Metric INO ZNTL Biotechnology median
P/E n/m n/m 10.26
P/S 310.99 n/m 9.18
P/B 27.45 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales 259.00 n/m 8.98
Earnings yield (78.57%) (114.04%) (34.89%)
Free cash flow yield (66.73%) (104.95%) (24.52%)

Profitability

Metric INO ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (66.75%) (50.12%)
Return on assets (114.64%) (49.22%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO ZNTL Biotechnology median
Revenue growth (TTM) (54.82%) — 6.26%
EPS growth (last fiscal year) 54.18% 18.03% 29.88%
Revenue growth, 5-year CAGR (61.18%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 4.82 4.89
Net debt to EBITDA 0.70 1.59 1.01

Dividend

Metric INO ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO ZNTL Biotechnology median
Market cap 167.50m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack